Organo (TSE:6368) Cyclically Adjusted Revenue per Share: 円2,797.77 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6368 Organo Corp TSE:6368
94 GF Score
Price 円12,420.00
GF Value 円9,395.11
Valuation Significantly Overvalued
View Full Analysis

What is Organo Cyclically Adjusted Revenue per Share?

Organo TSE:6368 -8.24% 94 Cyclically Adjusted Revenue per Share is 円2,797.77 as of Mar. 2026. GuruFocus rates TSE:6368 with a GF Score™ of 94/100 and a GF Value™ of 円9,395.11 (Significantly Overvalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Organo's adjusted revenue per share for the three months ended in Mar. 2026 was 円1,085.893. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円2,797.77 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Organo's average Cyclically Adjusted Revenue Growth Rate was 8.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Organo was 11.20% per year. The lowest was 4.20% per year. And the median was 8.05% per year.

As of today (2026-07-30), Organo's current stock price is 円12420.00. Organo's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円2,797.77. Organo's Cyclically Adjusted PS Ratio of today is 4.44.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Organo was 6.52. The lowest was 0.39. And the median was 1.09.


Organo  (TSE:6368) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Organo's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12420.00/2797.77
=4.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Organo was 6.52. The lowest was 0.39. And the median was 1.09.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Organo Cyclically Adjusted Revenue per Share Related Terms


Organo Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Organo's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organo Cyclically Adjusted Revenue per Share Chart

Organo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,869.91 2,062.06 2,295.60 2,569.38 2,797.77

Organo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,569.38 2,630.14 2,687.88 2,767.73 2,797.77

TSE:6368 vs VLTO, ZWS, CECO: Cyclically Adjusted Revenue per Share Comparison

For the Pollution & Treatment Controls subindustry, Organo's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organo Cyclically Adjusted PS Ratio vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Organo's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Organo's Cyclically Adjusted PS Ratio falls into.


TSE:6368
94GF Score
Organo Corp TSE:6368
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organo Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Organo's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1085.893/112.7000*112.7000
=1,085.893

Current CPI (Mar. 2026) = 112.7000.

Organo Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 330.757 98.100 379.983
201609 415.239 98.000 477.525
201612 362.987 98.400 415.738
201703 651.954 98.100 748.983
201706 292.170 98.500 334.290
201709 402.718 98.800 459.376
201712 393.469 99.400 446.116
201803 631.971 99.200 717.975
201806 367.637 99.200 417.668
201809 474.707 99.900 535.530
201812 494.038 99.700 558.456
201903 672.757 99.700 760.479
201906 440.974 99.800 497.974
201909 580.031 100.100 653.042
201912 451.384 100.500 506.179
202003 636.566 100.300 715.264
202006 427.508 99.900 482.284
202009 561.208 99.900 633.115
202012 509.620 99.300 578.390
202103 694.896 99.900 783.932
202106 485.907 99.500 550.369
202109 602.463 100.100 678.298
202112 606.265 100.100 682.578
202203 747.065 101.100 832.782
202206 607.512 101.800 672.560
202209 747.438 103.100 817.035
202212 719.423 104.100 778.857
202303 812.809 104.400 877.429
202306 645.310 105.200 691.316
202309 780.705 106.200 828.488
202312 887.319 106.800 936.338
202403 960.299 107.200 1,009.568
202406 688.207 108.200 716.829
202409 929.095 108.900 961.515
202412 900.122 110.700 916.384
202503 1,034.872 111.100 1,049.776
202506 829.271 111.700 836.695
202509 972.025 112.000 978.100
202512 977.231 113.000 974.637
202603 1,085.893 112.700 1,085.893

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円2,797.77 mean?
Organo (TSE:6368) has a Cyclically Adjusted Revenue per Share of 円2,797.77 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Organo and its competitors.
Is Organo's Cyclically Adjusted Revenue per Share too high?
Organo's current Cyclically Adjusted Revenue per Share is 円2,797.77. Overall, Organo has a GF Score™ of 94/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Organo's Cyclically Adjusted Revenue per Share compare to VLTO and ZWS?
Organo's Cyclically Adjusted Revenue per Share of 円2,797.77 can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Industrial Products company?
A good Cyclically Adjusted Revenue per Share depends on the Industrial Products industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Organo and its competitors. Organo's current Cyclically Adjusted Revenue per Share is 円2,797.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organo stock overvalued right now?
Based on GuruFocus' analysis, Organo (TSE:6368) is currently considered Significantly Overvalued. The stock's GF Value™ is 円9,395.11, compared to a current price of 円12,420.00 — trading 32.2% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円2,797.77. Organo's overall GF Score™ is 94/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Organo (TSE:6368), the current Cyclically Adjusted Revenue per Share is 円2,797.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organo (TSE:6368) Overvalued in 2026?

Based on GuruFocus' analysis, Organo stock appears to be overvalued. The current stock price of 円12,420.00 is trading 32.2% above its estimated GF Value™ of 円9,395.11. GuruFocus considers Organo to be Significantly Overvalued.

Key valuation signals for TSE:6368:

  • Cyclically Adjusted Revenue per Share: 円2,797.77
  • GF Value™: 円9,395.11 vs. price of 円12,420.00 (32.2% above fair value)
  • GF Score™: 94/100

No single metric tells the full story. See the TSE:6368 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Organo Business Description

Other Exchanges ORGJF:USA
Address 1-2-8 Shinsuna, Koto-ku, Tokyo, JPN, 136-8631
Organo Corp is a Japan-based company mainly engaged in the water treatment engineering business. The company operates in two business divisions namely water treatment engineering and functional product. Its water treatment engineering business includes manufacturing, delivery and maintenance of pure water systems, ultra-pure water systems and wastewater treatment systems for industries, condensate de mineralizers for power stations, waterworks and sewage treatment systems for the public sector. The functional product business encompasses the sale of standardized water treatment equipment, water treatment chemicals, and food processing materials.
94GF Score

Get the complete analysis for TSE:6368

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円12,420.00
Price
円9,395.11
GF Value